AJANTA PHARMA
Back to Balance Sheet
|
AJANTA PHARMA Last 5 Year Total Non-Current Assets History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Non-Current Assets | ₹1,871 Cr | ₹1,932 Cr | ₹1,891 Cr | ₹1,791 Cr | ₹1,605 Cr |
What is the latest Total Non-Current Assets ratio of AJANTA PHARMA ?
Year | Total Non-Current Assets |
---|---|
Mar2023 | ₹1,871 Cr |
Mar2022 | ₹1,932 Cr |
Mar2021 | ₹1,891 Cr |
Mar2020 | ₹1,791 Cr |
Mar2019 | ₹1,605 Cr |
How is Total Non-Current Assets of AJANTA PHARMA Trending?
Years | Total Non-Current Assets | % Change | |
---|---|---|---|
Mar2023 | ₹1,871 Cr | -3.19 | |
Mar2022 | ₹1,932 Cr | 2.17 | |
Mar2021 | ₹1,891 Cr | 5.60 | |
Mar2020 | ₹1,791 Cr | 11.57 | |
Mar2019 | ₹1,605 Cr | - |
Compare Total Non-Current Assets of peers of AJANTA PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AJANTA PHARMA | ₹30,377.2 Cr | -0.2% | 8.3% | 87.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹350,195.0 Cr | -1.1% | -2.9% | 55.1% | Stock Analytics | |
CIPLA | ₹118,275.0 Cr | 0.3% | 6.1% | 56.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹117,130.0 Cr | 8.2% | 11.5% | 27.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹102,998.0 Cr | -3.7% | 8.5% | 107.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,034.1 Cr | 1.8% | -4.7% | 32.3% | Stock Analytics |
AJANTA PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AJANTA PHARMA | -0.2% |
8.3% |
87.5% |
SENSEX | -2% |
-1.1% |
19.4% |
You may also like the below Video Courses